Observational studyBMC pediatrics2026
Diagnostic performance of lung ultrasound and procalcitonin in differentiating early neonatal pneumonia from transient tachypnea of the newborn.
Observational study in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly neonatal pneumonia and transient tachypnea of the newborn (TTN) often present with overlapping clinical features in late preterm and term neonates, making early etiological differentiation challenging.
objectiveTo evaluate and compare the diagnostic performance of lung ultrasound alone and in combination with serum procalcitonin for distinguishing early neonatal pneumonia from TTN in neonates born at or beyond 34 weeks' gestation.
methodsThis retrospective observational study included neonates ≥ 34 weeks' gestation admitted with respiratory distress within the first 72 h of life between January 2024 and January 2026. Lung ultrasound (LUS), chest radiography, and serum procalcitonin (PCT) measured at 24 h of life were available for all included neonates. The reference diagnosis was established based on clinical findings, chest radiography, and clinical course. Diagnostic performance of LUS, PCT, and their combination was evaluated using receiver operating characteristic analysis; PCT was primarily analyzed as a continuous variable, and an exploratory post hoc cutoff (≥ 6 ng/mL) was used for the combined model.
resultsA total of 78 neonates were included (31 with TTN and 47 with early neonatal pneumonia). Lung ultrasound demonstrated high diagnostic accuracy, with a sensitivity of 91.5%, specificity of 96.8%, and an area under the curve (AUC) of 0.945 (95% CI, 0.894-0.992). Procalcitonin alone showed limited diagnostic performance (sensitivity 53.2%, specificity 67.7%, AUC 0.615; 95% CI, 0.496-0.741). The combined LUS + PCT model yielded a numerically higher AUC of 0.964 (95% CI, 0.926-0.994), with a sensitivity of 93.6% and specificity of 96.8%. However, given the small absolute difference versus LUS alone (ΔAUC = 0.019), this increase should be interpreted cautiously.
conclusionsIn late preterm and term neonates with early respiratory distress, lung ultrasound showed high diagnostic accuracy for identifying early neonatal pneumonia. Procalcitonin alone showed limited discriminatory performance, and its addition to lung ultrasound did not provide robust evidence of a statistically reliable improvement over lung ultrasound alone in this retrospective cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.